Peringatan Keamanan

May induce ventricular extrasystoles and short paroxysms of ventricular tachycardia, a sensation of fullness in the head and tingling of the extremities; LD50=1490mg/kg (orally in rat)

Phenylpropanolamine

DB00397

small molecule approved vet_approved withdrawn

Deskripsi

Phenylpropanolamine is a sympathomimetic agent that acts as a nonselective adrenergic receptor agonist and norepinephrine reuptake inhibitor. It has been used as a decongestant and appetite suppressant. Currently, it is withdrawn from the market in Canada and the United States due to the risk for hemorrahgic strokes.

Struktur Molekul 2D

Berat 151.209
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 2.1 to 3.4 hours.
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Reduced bioavailability (about 38%) from gastrointestinal tract because of first pass metabolism by monoamine oxidase in the stomach and liver.

Metabolisme

Hepatic

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Makanan

2 Data
  • 1. Limit caffeine intake.
  • 2. Take with or without food. The absorption is unaffected by food.

Interaksi Obat

906 Data
Valsartan Phenylpropanolamine may decrease the antihypertensive activities of Valsartan.
Ramipril Phenylpropanolamine may decrease the antihypertensive activities of Ramipril.
Reserpine Phenylpropanolamine may decrease the antihypertensive activities of Reserpine.
Remikiren Phenylpropanolamine may decrease the antihypertensive activities of Remikiren.
Isradipine Phenylpropanolamine may decrease the antihypertensive activities of Isradipine.
Olmesartan Phenylpropanolamine may decrease the antihypertensive activities of Olmesartan.
Nitroprusside Phenylpropanolamine may decrease the antihypertensive activities of Nitroprusside.
Diltiazem Phenylpropanolamine may decrease the antihypertensive activities of Diltiazem.
Minoxidil Phenylpropanolamine may decrease the antihypertensive activities of Minoxidil.
Treprostinil Phenylpropanolamine may decrease the antihypertensive activities of Treprostinil.
Amlodipine Phenylpropanolamine may decrease the antihypertensive activities of Amlodipine.
Nimodipine Phenylpropanolamine may decrease the antihypertensive activities of Nimodipine.
Nisoldipine Phenylpropanolamine may decrease the antihypertensive activities of Nisoldipine.
Fosinopril Phenylpropanolamine may decrease the antihypertensive activities of Fosinopril.
Trandolapril Phenylpropanolamine may decrease the antihypertensive activities of Trandolapril.
Lercanidipine Phenylpropanolamine may decrease the antihypertensive activities of Lercanidipine.
Benazepril Phenylpropanolamine may decrease the antihypertensive activities of Benazepril.
Bosentan Phenylpropanolamine may decrease the antihypertensive activities of Bosentan.
Enalapril Phenylpropanolamine may decrease the antihypertensive activities of Enalapril.
Candoxatril Phenylpropanolamine may decrease the antihypertensive activities of Candoxatril.
Mecamylamine Phenylpropanolamine may decrease the antihypertensive activities of Mecamylamine.
Losartan Phenylpropanolamine may decrease the antihypertensive activities of Losartan.
Moexipril Phenylpropanolamine may decrease the antihypertensive activities of Moexipril.
Eplerenone Phenylpropanolamine may decrease the antihypertensive activities of Eplerenone.
Lisinopril Phenylpropanolamine may decrease the antihypertensive activities of Lisinopril.
Nitroglycerin Phenylpropanolamine may decrease the antihypertensive activities of Nitroglycerin.
Metyrosine Phenylpropanolamine may decrease the antihypertensive activities of Metyrosine.
Cryptenamine Phenylpropanolamine may decrease the antihypertensive activities of Cryptenamine.
Perindopril Phenylpropanolamine may decrease the antihypertensive activities of Perindopril.
Candesartan cilexetil Phenylpropanolamine may decrease the antihypertensive activities of Candesartan cilexetil.
Fenoldopam Phenylpropanolamine may decrease the antihypertensive activities of Fenoldopam.
Tadalafil Phenylpropanolamine may decrease the antihypertensive activities of Tadalafil.
Eprosartan Phenylpropanolamine may decrease the antihypertensive activities of Eprosartan.
Quinapril Phenylpropanolamine may decrease the antihypertensive activities of Quinapril.
Telmisartan Phenylpropanolamine may decrease the antihypertensive activities of Telmisartan.
Methyldopa Phenylpropanolamine may decrease the antihypertensive activities of Methyldopa.
Irbesartan Phenylpropanolamine may decrease the antihypertensive activities of Irbesartan.
Nitrendipine Phenylpropanolamine may decrease the antihypertensive activities of Nitrendipine.
Deserpidine Phenylpropanolamine may decrease the antihypertensive activities of Deserpidine.
Pentolinium Phenylpropanolamine may decrease the antihypertensive activities of Pentolinium.
Trimethaphan Phenylpropanolamine may decrease the antihypertensive activities of Trimethaphan.
Diazoxide Phenylpropanolamine may decrease the antihypertensive activities of Diazoxide.
Captopril Phenylpropanolamine may decrease the antihypertensive activities of Captopril.
Epoprostenol Phenylpropanolamine may decrease the antihypertensive activities of Epoprostenol.
Bepridil Phenylpropanolamine may decrease the antihypertensive activities of Bepridil.
Hydralazine Phenylpropanolamine may decrease the antihypertensive activities of Hydralazine.
Cilazapril Phenylpropanolamine may decrease the antihypertensive activities of Cilazapril.
Saprisartan Phenylpropanolamine may decrease the antihypertensive activities of Saprisartan.
Spirapril Phenylpropanolamine may decrease the antihypertensive activities of Spirapril.
Mibefradil Phenylpropanolamine may decrease the antihypertensive activities of Mibefradil.
Tienilic acid Phenylpropanolamine may decrease the antihypertensive activities of Tienilic acid.
Debrisoquine Phenylpropanolamine may decrease the antihypertensive activities of Debrisoquine.
Sitaxentan Phenylpropanolamine may decrease the antihypertensive activities of Sitaxentan.
Ambrisentan Phenylpropanolamine may decrease the antihypertensive activities of Ambrisentan.
Diethylnorspermine Phenylpropanolamine may decrease the antihypertensive activities of Diethylnorspermine.
Nilvadipine Phenylpropanolamine may decrease the antihypertensive activities of Nilvadipine.
Pinacidil Phenylpropanolamine may decrease the antihypertensive activities of Pinacidil.
Temocapril Phenylpropanolamine may decrease the antihypertensive activities of Temocapril.
Riociguat Phenylpropanolamine may decrease the antihypertensive activities of Riociguat.
Macitentan Phenylpropanolamine may decrease the antihypertensive activities of Macitentan.
Hexamethonium Phenylpropanolamine may decrease the antihypertensive activities of Hexamethonium.
Aliskiren Phenylpropanolamine may decrease the antihypertensive activities of Aliskiren.
Nicorandil Phenylpropanolamine may decrease the antihypertensive activities of Nicorandil.
Efonidipine Phenylpropanolamine may decrease the antihypertensive activities of Efonidipine.
Lacidipine Phenylpropanolamine may decrease the antihypertensive activities of Lacidipine.
Manidipine Phenylpropanolamine may decrease the antihypertensive activities of Manidipine.
Rauwolfia serpentina root Phenylpropanolamine may decrease the antihypertensive activities of Rauwolfia serpentina root.
Enalaprilat Phenylpropanolamine may decrease the antihypertensive activities of Enalaprilat.
Selexipag Phenylpropanolamine may decrease the antihypertensive activities of Selexipag.
Angiotensin 1-7 Phenylpropanolamine may decrease the antihypertensive activities of Angiotensin 1-7.
Imidapril Phenylpropanolamine may decrease the antihypertensive activities of Imidapril.
BQ-123 Phenylpropanolamine may decrease the antihypertensive activities of BQ-123.
Tetrahydropalmatine Phenylpropanolamine may decrease the antihypertensive activities of Tetrahydropalmatine.
Cicletanine Phenylpropanolamine may decrease the antihypertensive activities of Cicletanine.
Dihydralazine Phenylpropanolamine may decrease the antihypertensive activities of Dihydralazine.
Zofenopril Phenylpropanolamine may decrease the antihypertensive activities of Zofenopril.
Guanoxan Phenylpropanolamine may decrease the antihypertensive activities of Guanoxan.
Delapril Phenylpropanolamine may decrease the antihypertensive activities of Delapril.
Vincamine Phenylpropanolamine may decrease the antihypertensive activities of Vincamine.
Linsidomine Phenylpropanolamine may decrease the antihypertensive activities of Linsidomine.
Guanoxabenz Phenylpropanolamine may decrease the antihypertensive activities of Guanoxabenz.
Tolonidine Phenylpropanolamine may decrease the antihypertensive activities of Tolonidine.
Endralazine Phenylpropanolamine may decrease the antihypertensive activities of Endralazine.
Cadralazine Phenylpropanolamine may decrease the antihypertensive activities of Cadralazine.
Bietaserpine Phenylpropanolamine may decrease the antihypertensive activities of Bietaserpine.
Guanazodine Phenylpropanolamine may decrease the antihypertensive activities of Guanazodine.
Methoserpidine Phenylpropanolamine may decrease the antihypertensive activities of Methoserpidine.
Guanoclor Phenylpropanolamine may decrease the antihypertensive activities of Guanoclor.
Muzolimine Phenylpropanolamine may decrease the antihypertensive activities of Muzolimine.
Xipamide Phenylpropanolamine may decrease the antihypertensive activities of Xipamide.
Candesartan Phenylpropanolamine may decrease the antihypertensive activities of Candesartan.
Dexniguldipine Phenylpropanolamine may decrease the antihypertensive activities of Dexniguldipine.
Tocopherylquinone Phenylpropanolamine may decrease the antihypertensive activities of Tocopherylquinone.
Benazeprilat Phenylpropanolamine may decrease the antihypertensive activities of Benazeprilat.
Fosinoprilat Phenylpropanolamine may decrease the antihypertensive activities of Fosinoprilat.
Ramiprilat Phenylpropanolamine may decrease the antihypertensive activities of Ramiprilat.
Perindoprilat Phenylpropanolamine may decrease the antihypertensive activities of Perindoprilat.
Quinaprilat Phenylpropanolamine may decrease the antihypertensive activities of Quinaprilat.
Felodipine Phenylpropanolamine may decrease the antihypertensive activities of Felodipine.
Levamlodipine Phenylpropanolamine may decrease the antihypertensive activities of Levamlodipine.

Target Protein

D(1A) dopamine receptor DRD1
Beta-1 adrenergic receptor ADRB1
Beta-2 adrenergic receptor ADRB2
Alpha-2 adrenergic receptors ADRA2A

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 82 • International brands: 11
Produk
  • Antitussive Decong Antihistamine Syr
    Syrup • - • Oral • Canada • OTC • Approved
  • Bronchodex D Cap
    Capsule, extended release • - • Oral • Canada • OTC • Approved
  • Bronchosirum Pour Enfants
    Syrup • - • Oral • Canada • OTC • Approved
  • Caldomine Dh Adulte
    Liquid • - • Oral • Canada • Approved
  • Caldomine Dh Enfant
    Liquid • - • Oral • Canada • Approved
  • Centracol DM - Syr
    Syrup • - • Oral • Canada • OTC • Approved
  • Chlor Tripolon Decongest Syr
    Syrup • - • Oral • Canada • OTC • Approved
  • Cold & Allergy Relief - Liq
    Liquid • - • Oral • Canada • OTC • Approved
Menampilkan 8 dari 82 produk.
International Brands
  • Acutrim
  • Boxogetten — Cheplapharm
  • Dexatrim
  • Disudrin — Pediatrica
  • Naldec — IAE
  • Nasadec — Medlink
  • Nasathera — Morishita-Seggs
  • Propagest
  • Recatol mono — Riemser
  • Rhindecon

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul